8 recent drug approvals

8 drugs approved by the FDA in the last three months:

  1. FDA approves drug for gastrointestinal stromal tumors
    The FDA approved Qinlock, Deciphera Pharmaceuticals' drug designed to treat advanced gastrointestinal stromal tumors.

  2. FDA approves first drug for types of lung, thyroid cancers
    The FDA approved Retevmo, Eli Lilly's drug designed to treat three types of tumors – non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancers.

  3. FDA approves first drug to treat aggressive form of lung cancer
    The FDA approved Tabrecta, Novartis' drug designed to treat adult patients with non-small cell lung cancer that has spread to other parts of the body.

  4. FDA approves new treatment for a type of heart failure
    The FDA approved Farxiga, AstraZeneca's drug designed to treat heart failure.

  5. FDA approves first treatment for group of lung diseases
    The FDA approved Boehringer Ingelheim Pharmaceuticals' drug, Ofev, to treat adults with a group of progressive lung diseases.

  6. FDA approves Novartis' Cushing's disease drug
    The FDA has approved Novartis' drug, Isturisa, an oral tablet designed to treat Cushing's disease.

  7. FDA approves Sanofi's myeloma drug
    The FDA approved Sanofi's drug, Sarclisa, designed to treat multiple myeloma.

  8. FDA approves first generic version of drug that made Martin Shkreli infamous
    The FDA approved the first generic version of Daraprim, the lifesaving drug for which Martin Shkreli became infamous by raising the price by 4,000 percent overnight.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars